PeptiDream Inc. (TYO:4587)

Japan flag Japan · Delayed Price · Currency is JPY
2,141.00
+8.00 (0.38%)
Mar 28, 2025, 1:58 PM JST
52.28%
Market Cap 277.11B
Revenue (ttm) 46.68B
Net Income (ttm) 15.01B
Shares Out 129.61M
EPS (ttm) 115.68
PE Ratio 18.48
Forward PE 17.24
Dividend n/a
Ex-Dividend Date n/a
Volume 194,400
Average Volume 761,270
Open 2,140.00
Previous Close 2,133.00
Day's Range 2,133.00 - 2,174.50
52-Week Range 1,405.50 - 3,060.00
Beta 0.38
RSI 47.60
Earnings Date May 13, 2025

About PeptiDream

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform that enables the production of non-standard peptide libraries for the identification of potent and selective macrocyclic peptide candidates, which then can be developed into peptide-based, small molecule-based, peptide-drug conjugate, and multi-functional peptide conjugates... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 732
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4587
Full Company Profile

Financial Performance

In 2024, PeptiDream's revenue was 46.68 billion, an increase of 62.57% compared to the previous year's 28.71 billion. Earnings were 15.01 billion, an increase of 394.73%.

Financial Statements

News

PeptiDream: Opulent Dream Now A Reality

PeptiDream's PDPS platform offers a promising investment opportunity due to the new therapeutic class of macrocyclic peptide. Read my analysis of PPTDF stock.

3 months ago - Seeking Alpha